These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Granulocyte colony-stimulating factors. Med Lett Drugs Ther; 1991 Jun; 33(847):61-3. PubMed ID: 1710761 [No Abstract] [Full Text] [Related]
26. Hematopoietic growth factors as an adjunct for neutropenic patients in the ICU: still a controversial issue. Serke S Intensive Care Med; 1999 Sep; 25(9):901-2. PubMed ID: 10501743 [No Abstract] [Full Text] [Related]
27. Hematopoietic management in oncology practice. Part 1. Myeloid growth factors. Glaspy JA Oncology (Williston Park); 2003 Nov; 17(11):1593-603. PubMed ID: 14682110 [TBL] [Abstract][Full Text] [Related]
28. Growth factors and empiric therapy with antibiotics: should they be used concurrently? Schimpff SC Ann Intern Med; 1994 Oct; 121(7):538-40. PubMed ID: 7520677 [No Abstract] [Full Text] [Related]
29. Colony-stimulating factor use in the context of refined risk and benefit assessments. Crawford J Oncology (Williston Park); 2006 Apr; 20(5 Suppl 4):9-10. PubMed ID: 16736982 [No Abstract] [Full Text] [Related]
30. Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor. Hellmich B; Schnabel A; Gross WL Semin Arthritis Rheum; 1999 Oct; 29(2):82-99. PubMed ID: 10553980 [TBL] [Abstract][Full Text] [Related]
31. [Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF]. Borota R; Borota J; Belić A; Gebauer E; Stefanović N Med Pregl; 1997; 50(3-4):87-93. PubMed ID: 9229690 [TBL] [Abstract][Full Text] [Related]
32. [Report on the current indications for colony stimulating factors (G-CSF and GM-CSF)]. Med Clin (Barc); 1994 May; 102(19):747-50. PubMed ID: 7518884 [No Abstract] [Full Text] [Related]
33. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy. Wong SF; Chan HO Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284 [TBL] [Abstract][Full Text] [Related]
34. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2). Lieschke GJ; Burgess AW N Engl J Med; 1992 Jul; 327(2):99-106. PubMed ID: 1376442 [No Abstract] [Full Text] [Related]
35. [Macrophage-colony stimulating factor (M-CSF) and its use in clinical practice]. Groblewska M; Mroczko B; Szmitkowski M Pol Arch Med Wewn; 2004 Mar; 111(3):355-65. PubMed ID: 15230219 [No Abstract] [Full Text] [Related]
36. The use of growth factors with antibiotics in the setting of neutropenic fever. Hussein AM; Elkordy M; Peters WP Am J Med; 1996 Jan; 100(1):15-6. PubMed ID: 8579081 [No Abstract] [Full Text] [Related]
37. Outpatient management of the febrile neutropenic child with cancer. Patrick CC; Shenep JL Adv Pediatr Infect Dis; 1999; 14():29-47. PubMed ID: 10079848 [No Abstract] [Full Text] [Related]
38. Haemopoietic growth factors and childhood cancer. Hann IM Eur J Cancer; 1995; 31A(9):1476-8. PubMed ID: 7577075 [No Abstract] [Full Text] [Related]
39. G-CSF and GM-CSF in Neutropenia. Mehta HM; Malandra M; Corey SJ J Immunol; 2015 Aug; 195(4):1341-9. PubMed ID: 26254266 [TBL] [Abstract][Full Text] [Related]
40. [Current methods in the treatment of iatrogenic neutropenia]. Meriggi F; Zaniboni A Tumori; 2003; 89(6):12-20. PubMed ID: 14870835 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]